285 related articles for article (PubMed ID: 35126610)
41. External quality assurance in nongynecologic cytology: The Australasian experience.
Shield PW; Frost F; Finnimore JL; Wright RG; Cummings MC
Cancer Cytopathol; 2017 May; 125(5):349-361. PubMed ID: 28241108
[TBL] [Abstract][Full Text] [Related]
42. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
43. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
Kolte S; Zaheer S; Aden D; Ranga S
Cytojournal; 2022; 19():52. PubMed ID: 36128470
[TBL] [Abstract][Full Text] [Related]
44. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
Afify A; Pang L; Howell L
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
[TBL] [Abstract][Full Text] [Related]
46. The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center.
Patel T; Patel P; Mehta S; Shah M; Jetly D; Khanna N
Diagn Cytopathol; 2019 Aug; 47(8):776-782. PubMed ID: 31091023
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta-analysis in malignancy diagnosis.
Ahuja S; Ahuja R; Pandey S; Zaheer S
Cancer Cytopathol; 2024 Apr; ():. PubMed ID: 38613789
[TBL] [Abstract][Full Text] [Related]
48. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.
Yang H; Zhu J; Wang P
Medicine (Baltimore); 2023 Oct; 102(43):e35707. PubMed ID: 37904355
[TBL] [Abstract][Full Text] [Related]
49. The international system for reporting serous fluid cytopathology: The initial project survey.
VandenBussche CJ; Crothers B; Chandra A; Schmitt F; Kurtycz DFI
Cytopathology; 2023 May; 34(3):191-197. PubMed ID: 36752688
[TBL] [Abstract][Full Text] [Related]
50. The diagnosis of malignancy in effusion cytology: a pattern recognition approach.
Pereira TC; Saad RS; Liu Y; Silverman JF
Adv Anat Pathol; 2006 Jul; 13(4):174-84. PubMed ID: 16858151
[TBL] [Abstract][Full Text] [Related]
51. Evaluating Diagnostic Clarity: The Comparative Efficacy of BlueStain in Serous Effusion Cytology under the International System for Reporting Serous Fluid Cytopathology Reporting Framework.
Alves PM; Azevedo MT; Ferreira F; Tastekin E; Canberk S; Schmitt FC
Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893601
[TBL] [Abstract][Full Text] [Related]
52. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
[TBL] [Abstract][Full Text] [Related]
53. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
Straccia P; Chiappetta M; Magnini D; Cancellieri A
Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
[TBL] [Abstract][Full Text] [Related]
54. Converting fluid-based cytologic specimens to histologic specimens for immunohistochemistry.
Wallace KA; Goldschmidt MH; Patel RT
Vet Clin Pathol; 2015 Jun; 44(2):303-9. PubMed ID: 25639814
[TBL] [Abstract][Full Text] [Related]
55. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids.
Dadhich H; Toi PC; Siddaraju N; Sevvanthi K
Diagn Cytopathol; 2016 Nov; 44(11):874-879. PubMed ID: 27546351
[TBL] [Abstract][Full Text] [Related]
56. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
57. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
[TBL] [Abstract][Full Text] [Related]
58. Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions.
Cozzi I; Oprescu FA; Rullo E; Ascoli V
Diagn Cytopathol; 2018 Jan; 46(1):9-14. PubMed ID: 28994508
[TBL] [Abstract][Full Text] [Related]
59. A retrospective analysis of pleural effusion specimens based on the newly proposed International System for Reporting Serous Fluid Cytopathology.
Xu Y; Hu AY; Wang SM; Wang Q; Pan YC; Zhang SH
Diagn Cytopathol; 2021 Sep; 49(9):997-1007. PubMed ID: 34019334
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]